Lv7
3280 积分 2023-10-10 加入
Final analysis of nivolumab plus cabozantinib for advanced renal cell carcinoma from the randomized phase III CheckMate 9ER trial
8天前
已完结
New Guidelines to Evaluate the Response to Treatment in Solid Tumors
9天前
已完结
The Efficacy and Safety of Anlotinib in Neoadjuvant Treatment of Locally Advanced Thyroid Cancer: A Single-Arm Phase II Clinical Trial
5个月前
已完结
A Phase Ii, Single-Arm Trial Of Neoadjuvant Axitinib Plus Avelumab In Patients With Localized Renal Cell Carcinoma Who Are At High Risk Of Relapse After Nephrectomy (Neoavax)
5个月前
已完结
Concurrent Trastuzumab Deruxtecan and Radiation Therapy in HER2-positive and HER2-low Metastatic Breast Cancer
8个月前
已完结
Clinical importance of the expression of CD4+CD8+ T cells in renal cell carcinoma
8个月前
已完结
First-Line Therapy For Advanced Non-Clear Cell Renal Cell Carcinoma: A Systematic Review and Meta-Analysis
8个月前
已完结
Re: First-line Therapy for Advanced Non–Clear Cell Renal Cell Carcinoma. A Systematic Review and Meta-analysis
8个月前
已关闭
Systemic therapy for non–clear cell renal cell carcinomas: A systematic review
8个月前
已完结
Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
9个月前
已完结
皖公网安备34019202002308
